| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Children's Cancer Group National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00005881 |
Purpose
RATIONALE: Questionnaires that measure quality of life may improve the ability to plan treatment for children with cancer.
PURPOSE: This randomized clinical trialis studying the quality of life in children treated for cancer.
| Condition | Intervention |
|
Cancer-Related Problem/Condition Leukemia Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific |
Procedure: quality-of-life assessment |
| MedlinePlus related topics: | Cancer Hodgkin's Disease Leukemia, Adult Acute Leukemia, Adult Chronic Leukemia, Childhood Lymphoma |
| Study Type: | Interventional |
| Study Design: | Other, Randomized |
| Official Title: | Assessment of Health/Quality of Life in Survivors of Childhood Cancer |
| Study Start Date: | April 2000 |
OBJECTIVES: I. Assess the validity and reliability of a quality of life questionnaire (MM-QOL) that is being developed for patients with previously or currently treated childhood cancers.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to age (8-12 vs 13-20) and treatment (current vs previous). Patients are randomized to one of two arms of the study. Arm I (Reliability): Patients will complete the same questionnaire two weeks apart. (age 13-20 stratum closed as of 7/14/00) Arm II (Validity): Patients will complete a study questionnaire plus a Child Health Questionnaire. Patients between ages 8-12 are interviewed and patients between ages 13-20 complete a written questionnaire.
PROJECTED ACCRUAL: A total of 716 patients (416 for arm I (208 for 8-12 age group and 208 for 13-20 age group) and 300 for arm II (150 for 8-12 age group and 150 for 13-20 age group)) will be accrued for this study.
Eligibility
| Ages Eligible for Study: | 8 Years to 20 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS: Prior or current diagnosis of any pediatric cancer Current chemoradiotherapy (at least 2 months since start of therapy) OR At least 1 year since prior treatment and in remission
PATIENT CHARACTERISTICS: Age: 8 to 20 Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics Surgery: Not specified
Contacts and Locations| United States, California | |||||
| Cancer Center and Beckman Research Institute, City of Hope | |||||
| Duarte, California, United States, 91010-3000 | |||||
| CCOP - Bay Area Tumor Institute | |||||
| Oakland, California, United States, 94609-3305 | |||||
| United States, Colorado | |||||
| CCOP - Colorado Cancer Research Program, Inc. | |||||
| Denver, Colorado, United States, 80209-5031 | |||||
| United States, Delaware | |||||
| CCOP - Christiana Care Health Services | |||||
| Wilmington, Delaware, United States, 19899 | |||||
| United States, Iowa | |||||
| CCOP - Iowa Oncology Research Association | |||||
| Des Moines, Iowa, United States, 50309-1016 | |||||
| United States, Michigan | |||||
| CCOP - Grand Rapids Clinical Oncology Program | |||||
| Grand Rapids, Michigan, United States, 49503 | |||||
| University of Michigan Comprehensive Cancer Center | |||||
| Ann Arbor, Michigan, United States, 48109-0752 | |||||
| United States, Minnesota | |||||
| CCOP - Duluth | |||||
| Duluth, Minnesota, United States, 55805 | |||||
| Children's Hospitals and Clinics - Minneapolis | |||||
| Minneapolis, Minnesota, United States, 55404 | |||||
| Children's Hospitals and Clinics of Minnesota | |||||
| Saint Paul, Minnesota, United States, 55102 | |||||
| United States, Nevada | |||||
| CCOP - Southern Nevada Cancer Research Foundation | |||||
| Las Vegas, Nevada, United States, 89106 | |||||
| United States, New York | |||||
| Memorial Sloan-Kettering Cancer Center | |||||
| New York, New York, United States, 10021 | |||||
| United States, North Dakota | |||||
| CCOP - Merit Care Hospital | |||||
| Fargo, North Dakota, United States, 58122 | |||||
| United States, Pennsylvania | |||||
| CCOP - Geisinger Clinic and Medical Center | |||||
| Danville, Pennsylvania, United States, 17822-2001 | |||||
| Children's Hospital of Philadelphia | |||||
| Philadelphia, Pennsylvania, United States, 19104 | |||||
| United States, South Dakota | |||||
| CCOP - Sioux Community Cancer Consortium | |||||
| Sioux Falls, South Dakota, United States, 57104 | |||||
| United States, Wisconsin | |||||
| CCOP - Marshfield Medical Research and Education Foundation | |||||
| Marshfield, Wisconsin, United States, 54449 | |||||
| Children's Cancer Group |
| National Cancer Institute (NCI) |
| Study Chair: | Smita Bhatia, MD | Beckman Research Institute |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
|
| Study ID Numbers: | CDR0000067920, CCG-AS972, CCG-S9702, NCI-P00-0148 |
| First Received: | June 2, 2000 |
| Last Updated: | October 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00005881 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
